Literature DB >> 17628642

Homeopathic remedy for arsenic toxicity?: Evidence-based findings from a randomized placebo-controlled double blind human trial.

Philippe Belon1, Antara Banerjee, Susanta Roy Karmakar, Surjyo Jyoti Biswas, Sandipan Chaki Choudhury, Pathikrit Banerjee, Jayanta Kumar Das, Surajit Pathak, Bibhas Guha, Saili Paul, Nandini Bhattacharjee, Anisur Rahman Khuda-Bukhsh.   

Abstract

Millions of people are at risk of groundwater arsenic contamination, but supply of arsenic-free drinking water is grossly inadequate. The present study was intended to examine if a potentized homeopathic remedy reportedly showing ameliorating potentials in people inhabiting high-risk arsenic-contaminated areas but drinking arsenic-free water, can also ameliorate arsenic toxicity in subjects living in high-risk arsenic-contaminated areas, and drinking arsenic-contaminated water. This pilot study was conducted on 20 males and 19 females of village Dasdiya (arsenic contaminated) who initially agreed to act as volunteers; but as many as 14, mostly placebo-fed subjects, later dropped out. 18 volunteers, 14 males and 4 females, from a distant village, Padumbasan (arsenic-free), served as negative controls. In a double blind placebo-controlled study, a potentized remedy of homeopathic Arsenicum Album-30 and its placebo (Succussed Alcohol-30) were given randomly to volunteers. Arsenic contents in urine and blood and several widely accepted toxicity biomarkers and pathological parameters in blood were analyzed before and after 2 months of administration of either verum or placebo. Elevated levels of ESR, creatinine and eosinophils and increased activities of AST, ALT, LPO and GGT were recorded in arsenic exposed subjects. Decreased levels of hemoglobin, PCV, neutrophil percentages, and GSH content and low G-6-PD activity were also observed in the arsenic exposed people. The administration of "verum" appeared to make positive modulations of these parameters, suggestive of its ameliorative potentials. Most of the subjects reported better appetite and improvement in general health, thereby indicating possibility of its use in remote arsenic-contaminated areas as an interim health support measure to a large population at risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628642     DOI: 10.1016/j.scitotenv.2007.06.001

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  5 in total

1.  Two Cases of Fulminant Hepatic Failure from Amanita phalloides Poisoning Treated Additively by Homeopathy.

Authors:  Michael Frass; Petko Zagorchev; Vasilka Yurukova; Beatrix Wulkersdorfer; Karin Thieves; Konstantin Zedtwitz-Liebenstein; Willfried Bursch; Alan David Kaye
Journal:  Ochsner J       Date:  2014

2.  First aid interventions by laypeople for acute oral poisoning.

Authors:  Bert Avau; Vere Borra; Anne-Catherine Vanhove; Philippe Vandekerckhove; Peter De Paepe; Emmy De Buck
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

3.  Can homeopathy bring additional benefits to thalassemic patients on hydroxyurea therapy? Encouraging results of a preliminary study.

Authors:  Antara Banerjee; Sudipa Basu Chakrabarty; Susanta Roy Karmakar; Amit Chakrabarty; Surjyo Jyoti Biswas; Saiful Haque; Debarsi Das; Saili Paul; Biswapati Mandal; Boujedaini Naoual; Philippe Belon; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

4.  A Follow-Up Study on the Efficacy of the Homeopathic Remedy Arsenicum album in Volunteers Living in High Risk Arsenic Contaminated Areas.

Authors:  Anisur Rahman Khuda-Bukhsh; Susanta Roy-Karmakar; Antara Banerjee; Pathikrit Banerjee; Surajit Pathak; Surjyo Jyoti Biswas; Saiful Haque; Debarsi Das; Naoual Boujedaini; Philippe Belon
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

5.  Successful Treatment of Chronic Viral Hepatitis With High-dilution Medicine.

Authors:  Barbara Sarter; Prasanta Banerji; Pratip Banerji
Journal:  Glob Adv Health Med       Date:  2012-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.